The airway management tube market is expected to witness a CAGR of 5% over the forecast period.
COVID-19 impacted the growth of the pulmonary drug delivery systems market. Patients suffering from respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) were at high risk of getting coronavirus infection. This has increased the demand for airway management devices and tubes for clearing obstructions. For instance, according to an article published in Pulmonary Medicine, in March 2022, it was observed that COPD patients have worse outcomes from the coronavirus infection. Also, due to biological factors, COPD patients are more likely to acquire viral infections and suffer from COVID-19's pathophysiological effects, such as micro thrombosis, intrapulmonary shunting, and subsequent bacterial infection. Thus, the increasing risk of developing COVID-19 infection among COPD patients has increased the demand for supraglottic and infraglottic devices, which increased the demand for airway management tubes during COVID-19. Hence, the COVID-19 pandemic had a favorable impact on the market initially. Currently, post-pandemic, the market has lost some traction. However, it is expected to have stable growth during the forecast period.
Factors such as the rise in incidence and prevalence of respiratory diseases, the increasing number of surgical procedures coupled with growing demand for emergency care, and increasing product approvals are boosting the market growth.
The prevalence and incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, and others among the population are increasing rapidly, which is anticipated to propel the market growth. For instance, according to an article published in ERS Journal, in August 2022, it was projected that about 645.6 million people (454.4 million men and 191.2 million women) are expected to have COPD by 2050, representing a 36% relative increase in global prevalence as compared to the previous year. Thus, the prevalence of COPD, a serious public health issue, is expected to rise, especially in emerging countries which is anticipated to increase the demand for airway management tubes. This is expected to fuel the market growth over the forecast period.
Additionally, as per an article published in PLOS One, in January 2021, about 2.8 million people in France are expected to have chronic obstructive pulmonary disease (COPD) by 2025. Thus, the expected increase in the number of people suffering from COPD is expected to increase the demand for airway management devices, thereby bolstering market growth.
Furthermore, the rising company activities in developing airway management systems that check for airway tube obstruction are also expected to increase the market growth over the forecast period. For instance, in May 2021, Medtronic launched its SonarMed airway monitoring system, which checks for endotracheal tube (ETT) obstruction in the United States. The device analyses ETT blockage and verifies the current position using acoustic technology and provides essential information necessary for making informed decisions on how to treat newborns and babies.
Therefore, owing to factors such as the rising burden of respiratory diseases, increasing surgical procedures as well as growing company activities, the studied market is expected to grow over the forecast period. However, the high cost of surgical procedures, lack of healthcare infrastructure, and awareness in low-income countries are expected to hinder the growth of the airway management tubes market over the forecast period.
The laryngoscope is a device used during intubation to aid in the vision of the trachea. Endotracheal tubes can be inserted into the trachea while being seen directly through a laryngoscope, which is also used to view the vocal cords. The two main types are the curved Macintosh blade and the straight blade (i.e., Miller with a curved tip and Wisconsin or Foregger with a straight tip).
The video laryngoscopes can aid in getting a view of the larynx by allowing indirect visualization of the glottic opening without lining up the pharyngeal, oral, and tracheal axes. They can also facilitate endotracheal intubation in patients with conditions (restricted mouth opening, inability to flex the neck) that can make traditional laryngoscopy challenging or impossible.
Furthermore, the rising company activities in developing technologically advanced products increase their availability in the market, contributing to market growth. For instance, in November 2021, Ambu Inc. awarded a contract in the category of Video Laryngoscopes to Vizient Inc. The contract covers Ambu’s King Vision video laryngoscope system, which enables quick and easy intubation with a display providing a consistent, clear, and real-time view of a patient’s airway. Also, in June 2021, Penlon Limited launched a new and improved range of laryngoscope blades and handles for use in the MRI suite. The Penlon MRI Green System Laryngoscope Range provides clinicians with the ability to safely intubate patients in a static magnetic field up to 1000 gauss/cm.
Therefore, owing to the rising product launches and company activities, the studied segment is expected to grow over the forecast period.
In addition, the rising geriatric population is more prone to develop chronic diseases such as cardiovascular diseases and others that require airway management. Also, parapharyngeal fat accumulation occurs with aging, which predisposes elderly patients to obstructive sleep apnea as well as an increased risk of desaturation events. This is expected to raise the need for airway management devices and tubes, hence propelling the market growth. For instance, according to the 2022 statistics published by UNPF, about 17%, 19%, and 8% of the population living in the United States, Canada, and Mexico, respectively, was aged 65 years and above in 2022.
Furthermore, the rising burden of respiratory diseases such as COPD, asthma, lung cancer, and others among the population is the key factor driving the market growth. For instance, as per 2022 statistics published by the ACS, about 236,740 people were expected to be diagnosed with lung cancer cases in the United States in 2022. The expected increase in the number of lung cancer cases raises the need for suctioning, which can help to prevent infection in lung cancer patients who are suffering from a respiratory emergency. This is expected to augment the market growth over the forecast period.
Moreover, the increasing product approvals in the region are also contributing to the market growth. For instance, in December 2021, Olympus received FDA approval for its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures.
Therefore, owing to factors such as the increasing burden of respiratory diseases, the growing geriatric population, and rising product approvals, the studied market is expected to grow over the forecast period in the North American region.
This product will be delivered within 2 business days.
COVID-19 impacted the growth of the pulmonary drug delivery systems market. Patients suffering from respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) were at high risk of getting coronavirus infection. This has increased the demand for airway management devices and tubes for clearing obstructions. For instance, according to an article published in Pulmonary Medicine, in March 2022, it was observed that COPD patients have worse outcomes from the coronavirus infection. Also, due to biological factors, COPD patients are more likely to acquire viral infections and suffer from COVID-19's pathophysiological effects, such as micro thrombosis, intrapulmonary shunting, and subsequent bacterial infection. Thus, the increasing risk of developing COVID-19 infection among COPD patients has increased the demand for supraglottic and infraglottic devices, which increased the demand for airway management tubes during COVID-19. Hence, the COVID-19 pandemic had a favorable impact on the market initially. Currently, post-pandemic, the market has lost some traction. However, it is expected to have stable growth during the forecast period.
Factors such as the rise in incidence and prevalence of respiratory diseases, the increasing number of surgical procedures coupled with growing demand for emergency care, and increasing product approvals are boosting the market growth.
The prevalence and incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, and others among the population are increasing rapidly, which is anticipated to propel the market growth. For instance, according to an article published in ERS Journal, in August 2022, it was projected that about 645.6 million people (454.4 million men and 191.2 million women) are expected to have COPD by 2050, representing a 36% relative increase in global prevalence as compared to the previous year. Thus, the prevalence of COPD, a serious public health issue, is expected to rise, especially in emerging countries which is anticipated to increase the demand for airway management tubes. This is expected to fuel the market growth over the forecast period.
Additionally, as per an article published in PLOS One, in January 2021, about 2.8 million people in France are expected to have chronic obstructive pulmonary disease (COPD) by 2025. Thus, the expected increase in the number of people suffering from COPD is expected to increase the demand for airway management devices, thereby bolstering market growth.
Furthermore, the rising company activities in developing airway management systems that check for airway tube obstruction are also expected to increase the market growth over the forecast period. For instance, in May 2021, Medtronic launched its SonarMed airway monitoring system, which checks for endotracheal tube (ETT) obstruction in the United States. The device analyses ETT blockage and verifies the current position using acoustic technology and provides essential information necessary for making informed decisions on how to treat newborns and babies.
Therefore, owing to factors such as the rising burden of respiratory diseases, increasing surgical procedures as well as growing company activities, the studied market is expected to grow over the forecast period. However, the high cost of surgical procedures, lack of healthcare infrastructure, and awareness in low-income countries are expected to hinder the growth of the airway management tubes market over the forecast period.
Airway Management Tubes Market Trends
Laryngoscope Segment Expected to Register a Significant Growth Over the Forecast Period
The laryngoscopes segment is expected to witness significant growth in the airway management tubes market over the forecast period. The factors attributing to the segment growth are the increasing prevalence and incidence of respiratory diseases, larynx cancer, growing demand for laryngoscopy procedures, and increasing company activities.The laryngoscope is a device used during intubation to aid in the vision of the trachea. Endotracheal tubes can be inserted into the trachea while being seen directly through a laryngoscope, which is also used to view the vocal cords. The two main types are the curved Macintosh blade and the straight blade (i.e., Miller with a curved tip and Wisconsin or Foregger with a straight tip).
The video laryngoscopes can aid in getting a view of the larynx by allowing indirect visualization of the glottic opening without lining up the pharyngeal, oral, and tracheal axes. They can also facilitate endotracheal intubation in patients with conditions (restricted mouth opening, inability to flex the neck) that can make traditional laryngoscopy challenging or impossible.
Furthermore, the rising company activities in developing technologically advanced products increase their availability in the market, contributing to market growth. For instance, in November 2021, Ambu Inc. awarded a contract in the category of Video Laryngoscopes to Vizient Inc. The contract covers Ambu’s King Vision video laryngoscope system, which enables quick and easy intubation with a display providing a consistent, clear, and real-time view of a patient’s airway. Also, in June 2021, Penlon Limited launched a new and improved range of laryngoscope blades and handles for use in the MRI suite. The Penlon MRI Green System Laryngoscope Range provides clinicians with the ability to safely intubate patients in a static magnetic field up to 1000 gauss/cm.
Therefore, owing to the rising product launches and company activities, the studied segment is expected to grow over the forecast period.
North America Expected to Have Significant Market Share Over the Forecast Period
North America is anticipated to witness significant growth in the airway management tubes market over the forecast period owing to the factors such as the rising burden of respiratory diseases, increasing surgical procedures, high healthcare expenditures, and increasing product launches.In addition, the rising geriatric population is more prone to develop chronic diseases such as cardiovascular diseases and others that require airway management. Also, parapharyngeal fat accumulation occurs with aging, which predisposes elderly patients to obstructive sleep apnea as well as an increased risk of desaturation events. This is expected to raise the need for airway management devices and tubes, hence propelling the market growth. For instance, according to the 2022 statistics published by UNPF, about 17%, 19%, and 8% of the population living in the United States, Canada, and Mexico, respectively, was aged 65 years and above in 2022.
Furthermore, the rising burden of respiratory diseases such as COPD, asthma, lung cancer, and others among the population is the key factor driving the market growth. For instance, as per 2022 statistics published by the ACS, about 236,740 people were expected to be diagnosed with lung cancer cases in the United States in 2022. The expected increase in the number of lung cancer cases raises the need for suctioning, which can help to prevent infection in lung cancer patients who are suffering from a respiratory emergency. This is expected to augment the market growth over the forecast period.
Moreover, the increasing product approvals in the region are also contributing to the market growth. For instance, in December 2021, Olympus received FDA approval for its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures.
Therefore, owing to factors such as the increasing burden of respiratory diseases, the growing geriatric population, and rising product approvals, the studied market is expected to grow over the forecast period in the North American region.
Airway Management Tubes Market Competitor Analysis
The airway management tubes market is competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products at fewer prices. Some of the key players in the market are Medtronic PLC, Becton, Dickinson and Company, Smiths Medical Inc., Teleflex, Fisher and Paykel Healthcare, and Cook Medical, among others.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic PLC
- Becton, Dickinson & Company
- Smiths Medical Inc.
- Teleflex
- Fisher & Paykel Healthcare
- Cook Medical
- Tracoe Medical
- ConvaTec
- Pulmodyne Inc.
- Fuji System Corporation
Methodology
LOADING...
